![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: C5orf51 |
Gene summary for C5ORF51 |
![]() |
Gene information | Species | Human | Gene symbol | C5orf51 | Gene ID | 285636 |
Gene name | chromosome 5 open reading frame 51 | |
Gene Alias | C5orf51 | |
Cytomap | 5p13.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | A6NDU8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
285636 | C5orf51 | LZE2T | Human | Esophagus | ESCC | 2.27e-03 | 7.06e-01 | 0.082 |
285636 | C5orf51 | LZE4T | Human | Esophagus | ESCC | 4.07e-11 | 4.26e-01 | 0.0811 |
285636 | C5orf51 | LZE5T | Human | Esophagus | ESCC | 3.08e-06 | 6.42e-01 | 0.0514 |
285636 | C5orf51 | LZE7T | Human | Esophagus | ESCC | 6.68e-11 | 5.32e-01 | 0.0667 |
285636 | C5orf51 | LZE8T | Human | Esophagus | ESCC | 4.86e-05 | 3.26e-01 | 0.067 |
285636 | C5orf51 | LZE20T | Human | Esophagus | ESCC | 1.21e-14 | 5.86e-01 | 0.0662 |
285636 | C5orf51 | LZE24T | Human | Esophagus | ESCC | 8.83e-21 | 5.77e-01 | 0.0596 |
285636 | C5orf51 | LZE6T | Human | Esophagus | ESCC | 2.43e-17 | 8.15e-01 | 0.0845 |
285636 | C5orf51 | P1T-E | Human | Esophagus | ESCC | 4.79e-05 | 3.67e-01 | 0.0875 |
285636 | C5orf51 | P2T-E | Human | Esophagus | ESCC | 9.61e-30 | 4.70e-01 | 0.1177 |
285636 | C5orf51 | P4T-E | Human | Esophagus | ESCC | 8.73e-35 | 6.50e-01 | 0.1323 |
285636 | C5orf51 | P5T-E | Human | Esophagus | ESCC | 5.19e-21 | 3.96e-01 | 0.1327 |
285636 | C5orf51 | P8T-E | Human | Esophagus | ESCC | 1.36e-34 | 5.73e-01 | 0.0889 |
285636 | C5orf51 | P9T-E | Human | Esophagus | ESCC | 5.09e-14 | 3.24e-01 | 0.1131 |
285636 | C5orf51 | P10T-E | Human | Esophagus | ESCC | 3.15e-41 | 7.15e-01 | 0.116 |
285636 | C5orf51 | P11T-E | Human | Esophagus | ESCC | 1.06e-09 | 4.59e-01 | 0.1426 |
285636 | C5orf51 | P12T-E | Human | Esophagus | ESCC | 1.56e-39 | 6.62e-01 | 0.1122 |
285636 | C5orf51 | P15T-E | Human | Esophagus | ESCC | 2.43e-15 | 3.45e-01 | 0.1149 |
285636 | C5orf51 | P16T-E | Human | Esophagus | ESCC | 3.76e-28 | 5.43e-01 | 0.1153 |
285636 | C5orf51 | P17T-E | Human | Esophagus | ESCC | 1.82e-07 | 4.11e-01 | 0.1278 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
C5orf51 | SNV | Missense_Mutation | novel | c.864N>A | p.Phe288Leu | p.F288L | A6NDU8 | protein_coding | deleterious(0.04) | possibly_damaging(0.487) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
C5orf51 | SNV | Missense_Mutation | novel | c.770N>C | p.Gly257Ala | p.G257A | A6NDU8 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BH-A0B6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
C5orf51 | SNV | Missense_Mutation | c.263N>T | p.Pro88Leu | p.P88L | A6NDU8 | protein_coding | deleterious(0) | probably_damaging(0.976) | TCGA-C8-A1HM-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | doxorubicin | CR | |
C5orf51 | SNV | Missense_Mutation | c.464N>A | p.Arg155Lys | p.R155K | A6NDU8 | protein_coding | tolerated(0.88) | benign(0.007) | TCGA-D8-A1XU-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
C5orf51 | deletion | In_Frame_Del | c.31_39delCGAGTGGAA | p.Arg11_Glu13del | p.R11_E13del | A6NDU8 | protein_coding | TCGA-AN-A0FX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
C5orf51 | SNV | Missense_Mutation | c.136A>C | p.Lys46Gln | p.K46Q | A6NDU8 | protein_coding | deleterious(0.01) | possibly_damaging(0.866) | TCGA-A6-6141-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fu | SD | |
C5orf51 | SNV | Missense_Mutation | rs370411797 | c.533N>A | p.Arg178Gln | p.R178Q | A6NDU8 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
C5orf51 | SNV | Missense_Mutation | c.324N>G | p.Ile108Met | p.I108M | A6NDU8 | protein_coding | tolerated(0.24) | possibly_damaging(0.549) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
C5orf51 | SNV | Missense_Mutation | novel | c.166G>A | p.Glu56Lys | p.E56K | A6NDU8 | protein_coding | deleterious(0.04) | benign(0.006) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
C5orf51 | SNV | Missense_Mutation | c.162N>T | p.Glu54Asp | p.E54D | A6NDU8 | protein_coding | tolerated(0.78) | benign(0) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |